Publicacións nas que colabora con Manuel Campos Toimil (17)

2023

  1. Correction: A Review of Population Pharmacokinetic Analyses of Linezolid (Clinical Pharmacokinetics, (2022), 61, 6, (789-817), 10.1007/s40262-022-01125-2)

    Clinical Pharmacokinetics

  2. Vessel-on-a-Chip: A Powerful Tool for Investigating Endothelial COVID-19 Fingerprints

    Cells, Vol. 12, Núm. 9

2022

  1. A Review of Population Pharmacokinetic Analyses of Linezolid

    Clinical Pharmacokinetics, Vol. 61, Núm. 6, pp. 789-817

2021

  1. Therapeutic drug monitoring of anti-tumour necrosis factor-α agents in inflammatory bowel disease: Limits and improvements

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 5, pp. 2216-2227

  2. Therapeutic drug monitoring of voriconazole: Validation of a high performance liquid chromatography method and comparison with an ARK immunoassay

    European Journal of Hospital Pharmacy, Vol. 28, Núm. 3, pp. 154-159

2020

  1. A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations

    British Journal of Clinical Pharmacology, Vol. 86, Núm. 8, pp. 1661-1666

  2. Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study

    Pharmacotherapy, Vol. 40, Núm. 1, pp. 17-25

2019

  1. An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting

    Journal of Chemotherapy, Vol. 31, Núm. 1, pp. 49-57

2007

  1. Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes

    European Journal of Pharmacology, Vol. 577, Núm. 1-3, pp. 91-99

2006

  1. Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta

    British Journal of Pharmacology, Vol. 147, Núm. 3, pp. 269-280

2004

  1. (-)-Epigallocatechin-3-gallate induces contraction of the rat aorta by a calcium influx-dependent mechanism

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Núm. 5, pp. 496-506

2000

  1. Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro

    General Pharmacology: The Vascular System, Vol. 35, Núm. 2, pp. 95-105

1994

  1. Effects of hydralazine on contractile responses to α1 and α2-adrenoceptor agonists in isolated rubbed rat aorta

    General Pharmacology, Vol. 25, Núm. 1, pp. 165-172

  2. Pharmacological study of several effects of hydralazine in the bisected rat vas deferens

    European Journal of Pharmacology, Vol. 251, Núm. 1, pp. 83-90

1993

  1. Study of the mechanism of the relaxant action of (+)‐glaucine in rat vas deferens

    British Journal of Pharmacology, Vol. 110, Núm. 3, pp. 943-948

1992

  1. Effect of urethane on hydralazine-induced tachycardia in rats

    General Pharmacology, Vol. 23, Núm. 6, pp. 1143-1147

  2. Effects of Platelet Activating Factor on Contractions and Ca Influx Induced by Noradrenaline and Potassium in Rat Rubbed and Intact Aorta. Comparison with Its Hypotensive Effect in Anaesthetized Normotensive Rats

    Journal of Pharmacy and Pharmacology, Vol. 44, Núm. 4, pp. 344-348